Endothelial function and dysfunction. Part I
Top Cited Papers
- 1 January 2005
- journal article
- review article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 23 (1) , 7-17
- https://doi.org/10.1097/00004872-200501000-00004
Abstract
An enormous number of studies in the last two decades have been devoted to investigating the role of the endothelium in cardiovascular diseases. Nonetheless, the optimal methodology for investigating the multifaceted aspects of endothelial dysfunction is still under debate. Biochemical markers, molecular genetic tests and invasive and non-invasive tools with and without pharmacological and physiological stimuli have been introduced. Furthermore newer pharmacological tools have been proposed. However, the application of these methodologies should fulfil a number of requirements in order to provide conclusive answers in this area of research. Thus, the most relevant methodological issues in the research on endothelial function and dysfunction are summarized in this paper.Keywords
This publication has 67 references indexed in Scilit:
- Effects of Bezafibrate and Simvastatin on Endothelial Activation and Lipid Peroxidation in Hypercholesterolemia: Evidence of Different Vascular Protection by Different Lipid-Lowering TreatmentsJournal of Clinical Endocrinology & Metabolism, 2003
- Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular RiskNew England Journal of Medicine, 2003
- Vitamin E Supplementation Reduces Plasma Vascular Cell Adhesion Molecule-1 and von Willebrand Factor Levels and Increases Nitric Oxide Concentrations in Hypercholesterolemic PatientsJournal of Clinical Endocrinology & Metabolism, 2002
- Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial arteryJournal of the American College of Cardiology, 2002
- Current Concepts of the Pathogenesis of the Acute Coronary SyndromesCirculation, 2001
- Reciprocal regulation of endothelin-1 and nitric oxide: Relevance in the physiology and pathology of the cardiovascular systemPublished by Elsevier ,2001
- Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities.Diabetes, 1998
- Isoprostanes: Potential Markers of Oxidant Stress in Atherothrombotic DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Elevated plasma endothelin-1 levels as an additional risk factor in non-obese essential hypertensive patients with metabolic abnormalitiesDiabetologia, 1997
- Circulating and Tissue Endothelin Immunoreactivity in Advanced AtherosclerosisNew England Journal of Medicine, 1991